Literature DB >> 14663340

Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron.

Ya Hua1, Richard F Keep, Julian T Hoff, Guohua Xi.   

Abstract

Pretreatment with a low intracerebral dose of thrombin reduces brain edema after hemorrhagic and thrombo-embolic stroke. We have termed this phenomena thrombin preconditioning (TPC) or thrombin-induced brain tolerance. Red blood cell lysis and iron overload contribute to delayed edema formation after intracerebral hemorrhage. The present study examined whether TPC can attenuate the brain edema induced by lysed red blood cells or iron. It also examined whether TPC is associated with increasing hypoxia inducible factor-1alpha (HIF-1alpha) levels and alterations in two HIF-1alpha target genes, transferrin (Tf) and transferrin receptor (TfR), within the brain. Brain edema was measured by wet/dry weight method. HIF-1alpha, Tf, and TfR were measured by Western blot analysis and immunohistochemistry. We found that TPC reduces the edema induced by infusion of lysed red blood cells and iron. Thrombin increases HIF-1alpha levels through p44/42 mitogen activated protein kinases pathway. Thrombin also increases Tf and TfR levels in the brain. These results indicate that HIF-1alpha and its target genes may be involved in thrombin-induced brain tolerance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14663340     DOI: 10.1097/01.WCB.0000090621.86921.D5

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  23 in total

1.  Iron accumulation and neurotoxicity in cortical cultures treated with holotransferrin.

Authors:  Jing Chen-Roetling; Wenpei Liu; Raymond F Regan
Journal:  Free Radic Biol Med       Date:  2011-08-30       Impact factor: 7.376

2.  Deferoxamine attenuates iron-induced long-term neurotoxicity in rats with traumatic brain injury.

Authors:  Lijun Zhang; Rong Hu; Mei Li; Fei Li; Hui Meng; Gang Zhu; Jiangkai Lin; Hua Feng
Journal:  Neurol Sci       Date:  2012-04-27       Impact factor: 3.307

3.  Role of protease-activated receptor-1 in brain injury after experimental global cerebral ischemia.

Authors:  Jinhu Wang; Hang Jin; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Stroke       Date:  2012-07-17       Impact factor: 7.914

Review 4.  Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage.

Authors:  Brian Y Hwang; Geoffrey Appelboom; Amit Ayer; Christopher P Kellner; Ivan S Kotchetkov; Paul R Gigante; Raqeeb Haque; Michael Kellner; E Sander Connolly
Journal:  Cerebrovasc Dis       Date:  2010-12-21       Impact factor: 2.762

5.  Ischemic preconditioning attenuates brain edema after experimental intracerebral hemorrhage.

Authors:  Yangdong He; Murat Karabiyikoglu; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Transl Stroke Res       Date:  2012-04-17       Impact factor: 6.829

6.  A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats.

Authors:  Lin Li; Yihao Tao; Jun Tang; Qianwei Chen; Yang Yang; Zhou Feng; Yujie Chen; Liming Yang; Yunfeng Yang; Gang Zhu; Hua Feng; Zhi Chen
Journal:  Transl Stroke Res       Date:  2015-09-16       Impact factor: 6.829

Review 7.  Intercellular cross-talk in intracerebral hemorrhage.

Authors:  Yusuke Egashira; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Brain Res       Date:  2015-04-09       Impact factor: 3.252

8.  Is there a place for cerebral preconditioning in the clinic?

Authors:  Richard F Keep; Michael M Wang; Jianming Xiang; Ya Hua; Guohua Xi
Journal:  Transl Stroke Res       Date:  2010-01-14       Impact factor: 6.829

9.  Effect of iron chelators on methemoglobin and thrombin preconditioning.

Authors:  Jing Chen-Roetling; Jesse Sinanan; Raymond F Regan
Journal:  Transl Stroke Res       Date:  2012-12       Impact factor: 6.829

Review 10.  Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury.

Authors:  Wanqiu Chen; Robert P Ostrowski; Andre Obenaus; John H Zhang
Journal:  Exp Neurol       Date:  2008-11-11       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.